Reimbursement for use of the artificial intelligence (AI)-powered EchoGo Heart Failure platform in hospital outpatient settings for Medicare and Medicaid patients is expected to increase from $99.81 to $284.88 in 2024.
Use of an FDA-cleared artificial intelligence (AI)-enabled system, which reportedly facilitates earlier detection of heart failure with preserved ejection fraction (HFpEF), will generate higher outpatient reimbursement in 2024, according to newly issued coding updates from the Centers for Medicare and Medicaid Services (CMS).
In an update to the ambulatory payment classification (APC) for the Healthcare Common Procedure Coding System (HCPCS) code C9786, the CMS has increased reimbursement from $99.81 to $284.88 for use of the EchoGo Heart Failure system, according to Ultromics, the manufacturer of the platform. The increased reimbursement for the device will go into effect on January 1, 2024.
The EchoGo Heart Failure platform, which received FDA 510(k) clearance in December 2022, reportedly diagnoses HFpEF through analysis of a single echocardiogram view. An August 2023 study noted a 95 percent area under the receiver operating characteristic curve (AUC) in validation testing for HFpEF detection.
“Approximately 50 percent of non-invasive cardiac imaging tests are performed in office-based settings so there is exciting potential for this reimbursement decision to unlock new opportunity to further broaden adoption of our technology,” added Ross Upton, the CEO and founder of Ultromics.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
Study Finds High Concordance Between AI and Radiologists for Cervical Spine Fractures on CT
May 6th 2024Researchers found a 98.3 percent concordance between attending radiology reports and AI assessments for possible cervical spine fractures on CT, according to new research presented at the 2024 ARRS Annual Meeting.
New Literature Review Finds ChatGPT Effective in Radiology in 84 Percent of Studies
April 29th 2024While noting a variety of pitfalls with the chatbot ranging from hallucinations to improper citations, the review authors found the use of ChatGPT in radiology demonstrated “high performance” in 37 out of 44 studies.